Opexa Therapeutics (OPXA) Stock: Today Is The Day My Friends


Opexa Therapeutics Inc (NASDAQ: OPXA) is having a relatively strong day in the market today; at least, it has been in the green all morning. The reason is relatively simple. Today is the day that investors will vote with regard to a proposed merger. At the moment (10:36), OPXA is trading at $1.10 per share after a gain of $0.01 per share (0.93%) thus far today.

OPXA Investors Await Big News

As mentioned above, today could be a big day for Opexa Therapeutics. The company recently announced that it intends to acquire Acer Therapeutics, Inc. However, before doing so, they need to gain support from investors. That’s where today comes in. Today is the last day for shareholders to vote with regard to the potential merger.

At the moment, Institutional Shareholder Services Inc. and Glass, Lewis & Co. are both recommending that shareholders vote for the proposed merger. If the merger goes through, Acer Therapeutics will become the wholly-owned subsidiary of Opexa Therapeutics, which would be the surviving company in the merger.

However, it’s important that investors take the time to consider the options here and make their vote heard, especially if they are for the merger. After all, if you are for the merger and fail to vote, your vote will be the same as an “Against” vote. If you are a shareholder and would like to cast your vote, you can do so by calling:

Advantage Proxy, Inc.

Toll Free: (877) 870-8565

Collect: (206) 870-8565

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

What We’ll Be Watching For Ahead

Moving forward, the CNA Finance team will be keeping a close eye on OPXA. In particular, we’re interested in following the news surrounding the potential merger and hoping that the merger does indeed get executed. Nonetheless, we’ll continue to follow the story closely and bring the news to you as it breaks!

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!

* indicates required


Please enter your comment!
Please enter your name here